Weiss Multi-Strategy Advisers’s Ligand Pharmaceuticals LGND Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio LGND Stock Details LGND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-90,101	Closed	-$4.09M	–	585
2020 Q1	$4.09M	Buy	+90,101	New	+$5.11M	0.16%	180
2015 Q2	–	Sell	-16,030	Closed	-$771K	–	492
2015 Q1	$771K	Hold	16,030	–	–	0.03%	338
2014 Q4	$532K	Buy	+16,030	New	+$521K	0.02%	336
2014 Q2	–	Sell	-5,514	Closed	-$231K	–	835
2014 Q1	$231K	Sell	5,514 -6,140	-53%	-$256K	﹤0.01%	881
2013 Q4	$382K	Buy	11,654 +2,036	+21%	+$66.3K	0.01%	716
2013 Q3	$260K	Sell	9,618 -30,457	-76%	-$857K	0.01%	714
2013 Q2	$935K	Buy	+40,075	New	+$721K	0.03%	397

Other funds holding LGND

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

CCMLC

Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

SDJVC

St. Denis J. Villere & Co New Orleans, Louisiana $907M AUM 10.61% 1-Year Est. Return

Weiss Multi-Strategy Advisers's LGND Position: Q2 2020 in Review

Weiss Multi-Strategy Advisers sold out of Ligand Pharmaceuticals (LGND) in Q2 2020, closing a stake of 90,101 shares — an estimated $4.09M sold.

Weiss Multi-Strategy Advisers first reported a position in LGND in Q2 2013 and held it in 7 quarters. The position peaked at $4.09M in Q1 2020. 262 funds tracked by Wall St. Rank hold LGND as of Q2 2020.

Weiss Multi-Strategy Advisers reported no remaining Ligand Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 90,101 Ligand Pharmaceuticals shares in Q2 2020, an estimated $4.09M.
Weiss Multi-Strategy Advisers first reported a position in Ligand Pharmaceuticals in Q2 2013 and held it in 7 quarters.
Weiss Multi-Strategy Advisers's Ligand Pharmaceuticals position peaked at $4.09M in Q1 2020.
262 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2020.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q2 2020, filed 14 Aug 2020.